Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood and adolescence. Refractory/relapsed RMS patients present a bad prognosis that combined with the lack of specific biomarkers impairs the development of new therapies. Here, we utilize dynamic BH3 profiling (DBP), a functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcon, Clara, Manzano-Muñoz, Albert, Prada, Estela, Mora, Jaume, Soriano, Aroa, Guillén, Gabriela, Gallego, Soledad, Roma, Josep, Samitier, Josep, Villanueva, Alberto, Montero, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429859/
https://www.ncbi.nlm.nih.gov/pubmed/32801295
http://dx.doi.org/10.1038/s41419-020-02887-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429859/
https://www.ncbi.nlm.nih.gov/pubmed/32801295
http://dx.doi.org/10.1038/s41419-020-02887-y

Ejemplares similares